Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance.
Gunton
Jenny E
JE
Section on Cellular and Molecular Physiology, Joslin Diabetes Center, Boston, Massachusetts, USA. jenny.gunton@joslin.harvard.edu
Cheung
N Wah
NW
Hitchman
Rosemary
R
Hams
Graham
G
O'Sullivan
Christine
C
Foster-Powell
Kaye
K
McElduff
Aidan
A
D019540:Area Under Curve; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D015992:Body Mass Index; D002857:Chromium / Q000008:administration & dosage / Q000494:pharmacology*; D019587:Dietary Supplements; D004311:Double-Blind Method; D018149:Glucose Intolerance / Q000097:blood*; D005951:Glucose Tolerance Test; D006801:Humans; D008055:Lipids / Q000097:blood; D010919:Placebos; D015203:Reproducibility of Results
D001786:Blood Glucose; D008055:Lipids; D010919:Placebos; D002857:Chromium